Sutro Biopharma (STRO) Asset Utilization Ratio (2018 - 2025)

Sutro Biopharma (STRO) has 8 years of Asset Utilization Ratio data on file, last reported at 0.51 in Q4 2025.

• For the quarter ending Q4 2025, Asset Utilization Ratio rose 243.61% year-over-year to 0.51; the trailing twelve-month figure through Dec 2025 stood at 0.51 (up 243.61% YoY), and the FY2025 full-year result was 0.37, up 152.6% from the prior year.
• Asset Utilization Ratio climbed to 0.51 in Q4 2025, from 0.45 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.51 in Q4 2025 to a low of 0.11 in Q3 2023.
• A 5-year average of 0.24 and a median of 0.18 in 2022 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio slumped 56.59% in 2024 and surged 243.61% in 2025, its largest moves.
• Tracing STRO's Asset Utilization Ratio over 5 years: stood at 0.17 in 2021, then decreased by 3.33% to 0.17 in 2022, then surged by 103.0% to 0.34 in 2023, then tumbled by 56.59% to 0.15 in 2024, then surged by 243.61% to 0.51 in 2025.
• Business Quant data shows STRO's Asset Utilization Ratio at 0.51 in Q4 2025, 0.45 in Q3 2025, and 0.36 in Q2 2025.